Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Bierer

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Biological Psychiatry|August 1, 1995
Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's diseaseB A Lawlor, L M Bierer, T M Ryan, et al.
Biological Psychiatry|February 15, 1993
Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological studyD P Purohit, M Davidson, D P Perl, et al.
Schizophrenia Research|May 1, 1994
Cortical cholinergic markers in schizophreniaV Haroutunian, M Davidson, P D Kanof, et al.
Journal of Neurochemistry|February 1, 1995
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficitsL M Bierer, V Haroutunian, S Gabriel, et al.
Psychiatry Research|December 1, 1993
Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptomsL M Bierer, P J Knott, J M Schmeidler, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Biological Psychiatry|August 1, 1995
Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's diseaseB A Lawlor, L M Bierer, T M Ryan, et al.
Biological Psychiatry|February 15, 1993
Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological studyD P Purohit, M Davidson, D P Perl, et al.
Schizophrenia Research|May 1, 1994
Cortical cholinergic markers in schizophreniaV Haroutunian, M Davidson, P D Kanof, et al.
Journal of Neurochemistry|February 1, 1995
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficitsL M Bierer, V Haroutunian, S Gabriel, et al.
Psychiatry Research|December 1, 1993
Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptomsL M Bierer, P J Knott, J M Schmeidler, et al.
Pageof 3